Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Manitoba

$17,500.00

Preliminary Validation of a Novel Genetic Knowledge Scale for Familial Hypercholesterolemia: Evaluation of Face Validity and Concept Validity

EF 2023-24

Résumé
Familial hypercholesterolemia (FH) is a genetic disorder resulting in high cholesterol levels. Individuals with FH are at an increased risk for heart attacks, heart disease and heart failure at an early age. Treatment options are available for those who have been diagnosed with FH however, FH remains an under-diagnosed disorder. Increased screening methods for FH and the identification of at-risk individuals is required. In this study, we aim to begin the validation process of a tool known as the multidimensional model of informed choice (MMIC), a measure that will be used to quantify patient informed choice in the context of genetic screening for FH. The MMIC accounts for the knowledge, attitudes and behaviours of patients who are faced with a decision about genetic testing in order to provide data on patient reported outcomes. Patient feedback of an FH-specific knowledge scale will be analyzed in order to ensure that all items included in the scale are clear and useful in making a decision about genetic testing. Previous use of this tool has been in the context of prenatal, cancer and Fragile-X syndrome screening, where the MMIC has shown to be an effective model for assessing patient-informed choice. Genetic counsellors who specialize in cardiac genetics have recognized the need for an FH-specific MMIC as a measure for patient-reported outcomes in FH screening programs. Guidelines for genetic screening emphasize the need for individuals to understand the implications of genetic testing to ensure patient informed choice. Development of tools that can accurately measure patient informed choice are crucial in the assessment of informed decision making of patients who are eligible for genetic screening.
Programme
Master's Award: Canada Graduate Scholarships
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
506531
Name
Moss Emily R
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Preliminary Validation of a Novel Genetic Knowledge Scale for Familial Hypercholesterolemia: Evaluation of Face Validity and Concept Validity
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiac Genetics; Cardiovascular Disease; Concept Validity; Face Validity; Familial Hypercholesterolemia; Genetic Counselling; Genetic Testing; Informed Choice; Multidimensional Model Of Informed Choice; Patient-Reported Outcome Measure
Abstract
Familial hypercholesterolemia (FH) is a genetic disorder resulting in high cholesterol levels. Individuals with FH are at an increased risk for heart attacks, heart disease and heart failure at an early age. Treatment options are available for those who have been diagnosed with FH however, FH remains an under-diagnosed disorder. Increased screening methods for FH and the identification of at-risk individuals is required. In this study, we aim to begin the validation process of a tool known as the multidimensional model of informed choice (MMIC), a measure that will be used to quantify patient informed choice in the context of genetic screening for FH. The MMIC accounts for the knowledge, attitudes and behaviours of patients who are faced with a decision about genetic testing in order to provide data on patient reported outcomes. Patient feedback of an FH-specific knowledge scale will be analyzed in order to ensure that all items included in the scale are clear and useful in making a decision about genetic testing. Previous use of this tool has been in the context of prenatal, cancer and Fragile-X syndrome screening, where the MMIC has shown to be an effective model for assessing patient-informed choice. Genetic counsellors who specialize in cardiac genetics have recognized the need for an FH-specific MMIC as a measure for patient-reported outcomes in FH screening programs. Guidelines for genetic screening emphasize the need for individuals to understand the implications of genetic testing to ensure patient informed choice. Development of tools that can accurately measure patient informed choice are crucial in the assessment of informed decision making of patients who are eligible for genetic screening.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Moss, Emily R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~